Cited by 177Viral Infectious Diseases and Gene Expression in InsectsFault Detection and Control SystemsProtein purification and stability

Technology outlook for real‐time quality attribute and process parameter monitoring in biopharmaceutical development—A review

Wasalathanthri, Dhanuka P., Rehmann, Matthew S., Song, Yuanli, Gu, Yan, Mi, Luo, Shao, Chun, Chemmalil, Letha, Lee, Jongchan +4 more·2020·Biotechnology and Bioengineering

Abstract

Real‐time monitoring of bioprocesses by the integration of analytics at critical unit operations is one of the paramount necessities for quality by design manufacturing and real‐time release (RTR) of biopharmaceuticals. A well‐defined process analytical technology (PAT) roadmap enables the monitoring of critical process parameters and quality attributes at appropriate unit operations to develop an analytical paradigm that is capable of providing real‐time data. We believe a comprehensive PAT roadmap should entail not only integration of analytical tools into the bioprocess but also should address automated‐data piping, analysis, aggregation, visualization, and smart utility of data for advanced‐data analytics such as machine and deep learning for holistic process understanding. In this review, we discuss a broad spectrum of PAT technologies spanning from vibrational spectroscopy, multivariate data analysis, multiattribute chromatography, mass spectrometry, sensors, and automated‐sampling technologies. We also provide insights, based on our experience in clinical and commercial manufacturing, into data automation, data visualization, and smart utility of data for advanced‐analytics in PAT. This review is catered for a broad audience, including those new to the field to those well versed in applying these technologies. The article is also intended to give some insight into the strategies we have undertaken to implement PAT tools in biologics process development with the vision of realizing RTR testing in biomanufacturing and to meet regulatory expectations.

Integrity signals

Registry

Crossref · 10.1002/bit.27461

Cites

90 of 90 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Automated sampling systems such as MAST and Seg-Flow can draw samples from the bioprocess stream and deliver them to analytical devices for seamless analysis.

    “Automated sampling systems such as MAST and Seg‐Flow can draw the samples from the bioprocess stream and deliver them to the analytical devices for ensuing seamless analysis [45, 46, 47].”

Cites

Flagged first, then by citations

3 of the 93 references couldn’t be matched to a known paper.

Research works printed but not linked: 5

  1. Garidel P., 2006, Fourier‐transform mid‐infrared spectroscopy for analysis and screening of liquid protein formulations, Part 2: Detailed analysis and applications, BioProcess Technical, 4, 40
  2. Pepper C.(2016).Accelerate cell culture development using the modular automated sampling technology (MAST™) platform in an integrated bioprocess lab environment.ECI Symposium Series Retrieved fromhttp://dc.engconfintl.org/cellculture_xv/114
  3. Romero‐Torres S., 2018, Biopharmaceutical process model evolution‐enabling process knowledge continuum from an advanced process control perspective, American Pharmaceutical. Reviews, 21, 1
  4. USP. (2017).<1039> General chapter chemometrics.6831‐6849.
  5. Wasalathanthri D. P., 2020, Real time process monitoring in biologics development, American Pharmaceutical Reviews, 23, 72

Cited by

Sorted by citations

Authors
Wasalathanthri, D. P., Rehmann, M. S., Song, Y., Gu, Y., Mi, L., Shao, C., Chemmalil, L., Lee, J., Ghose, S., Borys, M. C., Ding, J., & Li, Z. J.
Affiliations
  • Bristol-Myers Squibb (United States) (US)
  • Biologics Process Development Bristol‐Myers Squibb Company Devens Massachusetts
Corresponding author
Wasalathanthri, Dhanuka P.
Venue
Biotechnology and Bioengineering
Publisher
Wiley
Published
2020-07
Volume
117
Issue
10
Pages
3182-3198
ISSN
  • 0006-3592 (ISSN-L)
  • 1097-0290
OpenAlex
W3035854730
Cited by
177
References
93
Citations by year
2026: 35 · 2025: 26 · 2024: 38 · 2023: 31 · 2022: 17 · 2021: 27 · 2020: 2
FWCI
1.88
Type
journal article
Language
en
Open access
closed
Locations
  • Biotechnology and Bioengineering (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Viral Infectious Diseases and Gene Expression in Insects
  • Physical Sciences › Engineering › Control and Systems Engineering › Fault Detection and Control Systems
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein purification and stability
Keywords
process analytical technology, real-time monitoring, biopharmaceutical manufacturing, quality by design, real-time release testing, critical quality attributes, critical process parameters, data automation, data visualization, machine learning, deep learning, vibrational spectroscopy, multivariate analysis, mass spectrometry, sensors, automated sampling, regulatory compliance
MeSH terms
Biological Products, Quality Control, Technology, Pharmaceutical

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review